Epitoly (300381.SZ) announced that the company holds 51% of Victory Presents GmbH (hereinafter referred to as “German VE”) and Phytobiotics Futterzatzstoffe GmbH (hereinafter referred to as “FitoBaer”) holds 49% of German VE shares. In order to further improve the overseas marketing network and improve the efficiency of management decisions, the company's wholly-owned subsidiary VTR Biotech PTY Limited (hereinafter referred to as “Australian VTR”) plans to use its own capital to acquire 49% of the German VE shares (hereinafter referred to as the “target shares”) held by Fito Baiao. The company signed the “German VE Share Acquisition Agreement” with Australian VTR, German VE, and Fito Baiao on May 21, 2024, local time in Germany. The consideration for the underlying equity transaction was 1,226,700 euros.
溢多利(300381.SZ)拟收购德国VE剩余49%股权 推进实施海外市场拓展战略
Etrix (300381.SZ) plans to acquire the remaining 49% of German VE shares to advance the implementation of overseas market expansion strategies
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.